ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 63 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $21,642 | +86.2% | 4,820 | +82.9% | 0.01% | +83.3% |
| Q3 2023 | $11,620 | -32.4% | 2,635 | 0.0% | 0.01% | -40.0% |
| Q2 2023 | $17,180 | -9.6% | 2,635 | 0.0% | 0.01% | -9.1% |
| Q1 2023 | $18,998 | -23.9% | 2,635 | 0.0% | 0.01% | -35.3% |
| Q4 2022 | $24,978 | -10.8% | 2,635 | 0.0% | 0.02% | -15.0% |
| Q3 2022 | $28,000 | +3.7% | 2,635 | 0.0% | 0.02% | +5.3% |
| Q2 2022 | $27,000 | +17.4% | 2,635 | +9.6% | 0.02% | +26.7% |
| Q1 2022 | $23,000 | -20.7% | 2,405 | 0.0% | 0.02% | -21.1% |
| Q4 2021 | $29,000 | -43.1% | 2,405 | 0.0% | 0.02% | -48.6% |
| Q3 2021 | $51,000 | +54.5% | 2,405 | +46.2% | 0.04% | +48.0% |
| Q2 2021 | $33,000 | +3200.0% | 1,645 | +3555.6% | 0.02% | +2400.0% |
| Q1 2021 | $1,000 | -50.0% | 45 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $2,000 | – | 45 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCVC Bio GP, LLC | 29,411 | $313,000 | 100.00% |
| Founders Fund VII Management, LLC | 3,773,530 | $40,188,000 | 93.02% |
| Gruss & Co., LLC | 363,778 | $3,874,000 | 26.99% |
| Founders Fund Growth Management, LLC | 407,017 | $4,334,000 | 12.66% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $44,387,000 | 5.09% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $43,719,000 | 5.06% |
| Intellectus Partners, LLC | 1,089,755 | $11,606,000 | 3.99% |
| ArchPoint Investors | 630,326 | $6,713,000 | 2.66% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $607,000 | 1.49% |
| Orbimed Advisors | 4,180,768 | $44,525,000 | 0.81% |